AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 11486240 — intervention group
Group type: COMPARATOR
Intervention: Amlodipine 10 mg/day
Number of subjects: 67
Study 11486240 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 67
Study 11486240 — intervention group
Group type: EXPERIMENTAL
Intervention: Diltiazem
Number of subjects: 67
Study 9568453 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril 2.5 mg twice daily
Number of subjects: 1532
Study 9568453 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril 5 mg twice daily
Number of subjects: 1532
Study 9568453 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril 10 mg twice daily
Number of subjects: 1532
Study 8112284 — intervention group
Group type: EXPERIMENTAL
Intervention: Flunitrazepam 2 mg
Number of subjects: 15
Study 8112284 — intervention group
Group type: EXPERIMENTAL
Intervention: Triazolam 0.25 mg
Number of subjects: 15
Study 3073803 — intervention group
Group type: EXPERIMENTAL
Intervention: Terbutaline SR 7.5 mg b.i.d.
Number of subjects: 9
Study 3073803 — intervention group
Group type: EXPERIMENTAL
Intervention: Terbutaline SR 7.5 mg in the morning and 15 mg in the evening
Number of subjects: 9
Study 3073803 — intervention group
Group type: COMPARATOR
Intervention: Placebo b.i.d.
Number of subjects: 9
Study 29189347 — intervention group
Group type: EXPERIMENTAL
Intervention: Exenatide (17.4 μg infusion for 6 hours and 15 minutes)
Number of subjects: 106
Study 29189347 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 106
Study 26690312 — intervention group
Group type: EXPERIMENTAL
Intervention: Latest generation drug-eluting stent (SYNERGY™ II; Boston Scientific)
Number of subjects: 1200
Study 26690312 — intervention group
Group type: COMPARATOR
Intervention: Bare metal stent (Rebel™; Boston Scientific)
Number of subjects: 1200
Study 26348175 — intervention group
Group type: EXPERIMENTAL
Intervention: Collaborative midwifery and laborist model
Number of subjects: 4884
Study 23032073 — intervention group
Group type: EXPERIMENTAL
Intervention: ABT-894 (4 mg BID)
Number of subjects: 243
Study 23032073 — intervention group
Group type: EXPERIMENTAL
Intervention: Atomoxetine (40 mg BID)
Number of subjects: 243
Study 23032073 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 243
Study 20606094 — intervention group
Group type: EXPERIMENTAL
Intervention: Gemcitabine plus cetuximab
Number of subjects: 720
Study 20606094 — intervention group
Group type: COMPARATOR
Intervention: Gemcitabine
Number of subjects: 720
Study 18714250 — intervention group
Group type: EXPERIMENTAL
Intervention: Open skill warm-up (15 minutes)
Number of subjects: 14
Study 18714250 — intervention group
Group type: COMPARATOR
Intervention: Closed skill warm-up (15 minutes)
Number of subjects: 14
Study 16152838 — intervention group
Group type: EXPERIMENTAL
Intervention: Vertebral manipulation (VM) therapy
Number of subjects: 150
Study 16152838 — intervention group
Group type: COMPARATOR
Intervention: Acupuncture therapy
Number of subjects: 150
Study 12940469 — intervention group
Group type: EXPERIMENTAL
Intervention: Familias Unidas intervention
Number of subjects: 167
Study 12940469 — intervention group
Group type: COMPARATOR
Intervention: No-intervention control
Number of subjects: 167
Study 10488597 — intervention group
Group type: EXPERIMENTAL
Intervention: Glutamine (0.3 g/kg enterally for 5 days)
Number of subjects: 9
Study 10488597 — intervention group
Group type: COMPARATOR
Intervention: Casein (0.3 g/kg enterally for 5 days)
Number of subjects: 9
Study 8561067 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 g butter
Number of subjects: 12
Study 8561067 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 g butter
Number of subjects: 12
Study 8561067 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 g olive oil
Number of subjects: 12
Study 8561067 — intervention group
Group type: EXPERIMENTAL
Intervention: 80 g olive oil
Number of subjects: 12
Study 8561067 — intervention group
Group type: EXPERIMENTAL
Intervention: Fat content of meals (various fats)
Number of subjects: 12
Study 1877740 — intervention group
Group type: EXPERIMENTAL
Intervention: Disulfiram (DS) implant (10 x 100 mg DS tablets)
Number of subjects: 76
Study 1877740 — intervention group
Group type: COMPARATOR
Intervention: Placebo (9 x 100 mg calcium phosphate tablets + 1 mg DS tablet)
Number of subjects: 76
Study 1877740 — intervention group
Group type: EXPERIMENTAL
Intervention: Disulfiram (DS) implant
Number of subjects: 76
Study 1877740 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (DS and PL)
Number of subjects: 76
Study 7015215 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxatomide (30 mg b.i.d. for 4 weeks)
Number of subjects: 35
Study 7015215 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 35
Study 7015215 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxatomide
Number of subjects: 35
Study 31142546 — intervention group
Group type: EXPERIMENTAL
Intervention: Cell phone counseling intervention
Number of subjects: 404
Study 31142546 — intervention group
Group type: EXPERIMENTAL
Intervention: Medication Possession Ratio (MPR) >90%
Number of subjects: 404
Study 28476263 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-session family-based integrated substance use and HIV/STI prevention intervention
Number of subjects: 47
Study 28476263 — intervention group
Group type: COMPARATOR
Intervention: Adolescent-only psychoeducation condition
Number of subjects: 47
Study 25251443 — intervention group
Group type: EXPERIMENTAL
Intervention: Paraneoplastic Ma antigen-like 1 positive expression
Number of subjects: 50
Study 25251443 — intervention group
Group type: COMPARATOR
Intervention: Negative expression of Paraneoplastic Ma antigen-like 1
Number of subjects: 50
Study 23353608 — intervention group
Group type: EXPERIMENTAL
Intervention: Gilthead sea bream fillets fed with 100% fishmeal (FM)
Number of subjects: 20
Study 23353608 — intervention group
Group type: COMPARATOR
Intervention: Gilthead sea bream fillets fed with partial replacement with plant proteins (PP)
Number of subjects: 20
Study 21670471 — intervention group
Group type: EXPERIMENTAL
Intervention: Thalidomide plus melphalan and prednisone (MPT)
Number of subjects: 1685
Study 19191134 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone intervention with asthma-specific questionnaire
Number of subjects: 52
Study 19191134 — intervention group
Group type: COMPARATOR
Intervention: Control group with general health questionnaire
Number of subjects: 52
Study 18193693 — intervention group
Group type: EXPERIMENTAL
Intervention: Comfrey extract
Number of subjects: 164
Study 18193693 — intervention group
Group type: COMPARATOR
Intervention: Diclofenac gel
Number of subjects: 164
Study 15017112 — intervention group
Group type: EXPERIMENTAL
Intervention: Tc‐99m‐HIgG
Number of subjects: 55
Study 15017112 — intervention group
Group type: EXPERIMENTAL
Intervention: In‐111‐HIgG
Number of subjects: 55
Study 15017112 — intervention group
Group type: COMPARATOR
Intervention: T‐B transport in BCRL (involved hand)
Number of subjects: 55
Study 15017112 — intervention group
Group type: COMPARATOR
Intervention: T‐B transport in BCRL (spared hand)
Number of subjects: 55
Study 15017112 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimum time to arrival of radioprotein in blood
Number of subjects: 55
Study 11822849 — intervention group
Group type: EXPERIMENTAL
Intervention: Bug busting (combing with special combs and hair conditioner)
Number of subjects: 30
Study 11822849 — intervention group
Group type: COMPARATOR
Intervention: Phenothrin lotion
Number of subjects: 30
Study 9726802 — intervention group
Group type: EXPERIMENTAL
Intervention: ACE inhibitors (captopril 25 to 50 mg daily or enalapril 10 to 40 mg daily)
Number of subjects: 11
Study 9726802 — intervention group
Group type: COMPARATOR
Intervention: Control group (healthy volunteers)
Number of subjects: 11
Study 8277547 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational pamphlet on the durable power of attorney for health care and a durable power of attorney for health care form mailed to patients
Number of subjects: 1101
Study 8277547 — intervention group
Group type: COMPARATOR
Intervention: Conventional care only (Control)
Number of subjects: 1101
Study 2568072 — intervention group
Group type: EXPERIMENTAL
Intervention: Active TENS
Number of subjects: 30
Study 2568072 — intervention group
Group type: COMPARATOR
Intervention: Placebo TENS
Number of subjects: 30
Study 2568072 — intervention group
Group type: COMPARATOR
Intervention: No TENS
Number of subjects: 30
Study 785297 — intervention group
Group type: EXPERIMENTAL
Intervention: Lithium
Number of subjects: 17
Study 785297 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study 31702622 — intervention group
Group type: EXPERIMENTAL
Intervention: Training intervention for healthcare workers
Number of subjects: 1113
Study 31702622 — intervention group
Group type: COMPARATOR
Intervention: Financial subsidy for pregnant women
Number of subjects: 1113
Study 28592581 — intervention group
Group type: EXPERIMENTAL
Intervention: Discontinuation of antibiotic therapy
Number of subjects: 240
Study 28592581 — intervention group
Group type: COMPARATOR
Intervention: Usual strategy of continuing antibiotic treatment
Number of subjects: 240
Study 26088151 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic Respiratory Disease Questionnaire (CRDQ)
Number of subjects: 85
Study 23757295 — intervention group
Group type: EXPERIMENTAL
Intervention: Patterned Sensory Enhancement (PSE) music combined with exercise
Number of subjects: 36
Study 23757295 — intervention group
Group type: COMPARATOR
Intervention: No-music group
Number of subjects: 36
Study 21607703 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium fructoborate supplementation for 15 days
Number of subjects: 60
Study 21607703 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 19759043 — intervention group
Group type: EXPERIMENTAL
Intervention: Once-daily dosing (ODD) of gentamicin
Number of subjects: 400
Study 19759043 — intervention group
Group type: COMPARATOR
Intervention: Multiple daily dosing (MDD) of gentamicin
Number of subjects: 400
Study 17726314 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate beer consumption (330 ml for women and 660 ml for men) for 30 days
Number of subjects: 57
Study 16335304 — intervention group
Group type: EXPERIMENTAL
Intervention: Immunomodulatory cytokines
Number of subjects: 0
Study 16335304 — intervention group
Group type: EXPERIMENTAL
Intervention: Cytokines with antimicrobial agents
Number of subjects: 0
Study 11723892 — intervention group
Group type: COMPARATOR
Intervention: Total Parenteral Nutrition (TPN)
Number of subjects: 171
Study 11723892 — intervention group
Group type: EXPERIMENTAL
Intervention: Early Enteral Nutrition (EEN)
Number of subjects: 171
Study 11723892 — intervention group
Group type: EXPERIMENTAL
Intervention: Early Enteral Immunonutrition (EEIN)
Number of subjects: 171
Study 11723892 — intervention group
Group type: EXPERIMENTAL
Intervention: EEN and EEIN
Number of subjects: 171
Study 11723892 — intervention group
Group type: EXPERIMENTAL
Intervention: EEN
Number of subjects: 171
Study 9501404 — intervention group
Group type: EXPERIMENTAL
Intervention: IVIG infusion rate of 0.08 ml/kg/min
Number of subjects: 42
Study 9501404 — intervention group
Group type: EXPERIMENTAL
Intervention: IVIG infusion rate of 0.06 ml/kg/min
Number of subjects: 42
Study 9501404 — intervention group
Group type: EXPERIMENTAL
Intervention: IVIG infusion rate of 0.04 ml/kg/min
Number of subjects: 42
Study 7995386 — intervention group
Group type: COMPARATOR
Intervention: 0.1 mg ANP inhalation
Number of subjects: 11
Study 7995386 — intervention group
Group type: COMPARATOR
Intervention: 1 mg ANP inhalation
Number of subjects: 11
Study 7995386 — intervention group
Group type: COMPARATOR
Intervention: 5 mg ANP inhalation
Number of subjects: 11
Study 7995386 — intervention group
Group type: COMPARATOR
Intervention: Nebulized salbutamol (control)
Number of subjects: 11
Study 2457768 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril 1 mg
Number of subjects: 5
Study 2457768 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril 5 mg
Number of subjects: 5
Study 2457768 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril 25 mg
Number of subjects: 5
Study 2457768 — intervention group
Group type: COMPARATOR
Intervention: Vehicle (control)
Number of subjects: 5
Study 30952135 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgery
Number of subjects: 222
Study 30952135 — intervention group
Group type: COMPARATOR
Intervention: Nonoperative treatment
Number of subjects: 222
Study 28198785 — intervention group
Group type: EXPERIMENTAL
Intervention: Ocriplasmin
Number of subjects: 62
Study 28198785 — intervention group
Group type: COMPARATOR
Intervention: Sham
Number of subjects: 62
Study 27068497 — intervention group
Group type: EXPERIMENTAL
Intervention: S-1 (tegafur, gimeracil, and oteracil potassium) concurrent with 3D-conformal radiotherapy (60Gy)
Number of subjects: 106
Study 27068497 — intervention group
Group type: COMPARATOR
Intervention: Gemcitabine concurrent with 3D-conformal radiotherapy (control group)
Number of subjects: 106
Study 27068497 — intervention group
Group type: EXPERIMENTAL
Intervention: S-1 (tegafur, gimeracil, and oteracil potassium)
Number of subjects: 106
Study 25445313 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous PDS suture reinforced with GORE BIO‐A Tissue Reinforcement prosthesis
Number of subjects: 0
Study 25445313 — intervention group
Group type: COMPARATOR
Intervention: Continuous PDS suture only
Number of subjects: 0
Study 21748252 — intervention group
Group type: EXPERIMENTAL
Intervention: ABT-089 40 mg QD
Number of subjects: 221
Study 21748252 — intervention group
Group type: EXPERIMENTAL
Intervention: ABT-089 40 mg BID
Number of subjects: 221
Study 21748252 — intervention group
Group type: EXPERIMENTAL
Intervention: ABT-089 (all doses)
Number of subjects: 221
Study 21748252 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 221
Study 18828797 — intervention group
Group type: EXPERIMENTAL
Intervention: Naltrexone with Medical Management (MM) without Combined Behavioral Intervention (CBI)
Number of subjects: 618
Study 18828797 — intervention group
Group type: COMPARATOR
Intervention: Placebo with Medical Management (MM) without Combined Behavioral Intervention (CBI)
Number of subjects: 618
Study 18828797 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined Behavioral Intervention (CBI)
Number of subjects: 618
Study 17880017 — intervention group
Group type: EXPERIMENTAL
Intervention: HPC5 group (5/mm3)
Number of subjects: 45
Study 17880017 — intervention group
Group type: COMPARATOR
Intervention: HPC50 group (50/mm3)
Number of subjects: 45
Study 16098001 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranitidine 300 mg b.d. (RCM group)
Number of subjects: 150
Study 16098001 — intervention group
Group type: COMPARATOR
Intervention: Omeprazole 20 mg b.d. (OCM group)
Number of subjects: 150
Study 12182969 — intervention group
Group type: EXPERIMENTAL
Intervention: Pilocarpine (5-mg tablets) three times daily for 1 month after treatment
Number of subjects: 130
Study 12182969 — intervention group
Group type: COMPARATOR
Intervention: Placebo three times daily for 1 month after treatment
Number of subjects: 130
Study 12182969 — intervention group
Group type: EXPERIMENTAL
Intervention: Pilocarpine
Number of subjects: 130
Study 12182969 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 130
Study 9794348 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct PTCA in AMI
Number of subjects: 20
Study 9794348 — intervention group
Group type: COMPARATOR
Intervention: Control group (elective PTCA)
Number of subjects: 20
Study 7662753 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer-based biofeedback system 1
Number of subjects: 0
Study 7662753 — intervention group
Group type: COMPARATOR
Intervention: Computer-based biofeedback system 2
Number of subjects: 0
Study 2675768 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative irradiation
Number of subjects: 166
Study 2675768 — intervention group
Group type: COMPARATOR
Intervention: No preoperative irradiation (Control)
Number of subjects: 166
Study 16319303 — intervention group
Group type: EXPERIMENTAL
Intervention: Donepezil
Number of subjects: 80
Study 16319303 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study 31124947 — intervention group
Group type: EXPERIMENTAL
Intervention: Mibyeongbogam (MBBG) mobile application for 12 weeks
Number of subjects: 150
Study 31124947 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 150
Study 28367916 — intervention group
Group type: EXPERIMENTAL
Intervention: Dulaglutide 0.75 mg
Number of subjects: 0
Study 28367916 — intervention group
Group type: COMPARATOR
Intervention: Liraglutide 0.9 mg
Number of subjects: 0
Study 28367916 — intervention group
Group type: COMPARATOR
Intervention: Insulin glargine
Number of subjects: 0
Study 28367916 — intervention group
Group type: EXPERIMENTAL
Intervention: All treatment groups
Number of subjects: 0
Study 28367916 — intervention group
Group type: EXPERIMENTAL
Intervention: Dulaglutide
Number of subjects: 0
Study 25430415 — intervention group
Group type: EXPERIMENTAL
Intervention: Raloxifene 60 mg/day
Number of subjects: 22
Study 23336124 — intervention group
Group type: EXPERIMENTAL
Intervention: Mirror therapy (MT), 30 minutes a day, five days a week for three weeks, plus half an hour conventional rehabilitation after each MT session
Number of subjects: 30
Study 23336124 — intervention group
Group type: COMPARATOR
Intervention: Control group observed the affected hand instead of using mirror therapy, same treatment programme as intervention group
Number of subjects: 30
Study 23336124 — intervention group
Group type: EXPERIMENTAL
Intervention: Mirror therapy (MT)
Number of subjects: 30
Study 23336124 — intervention group
Group type: COMPARATOR
Intervention: Control group observed the affected hand instead of using mirror therapy
Number of subjects: 30
Study 21463037 — intervention group
Group type: EXPERIMENTAL
Intervention: Applied Tension (AT) technique
Number of subjects: 737
Study 21463037 — intervention group
Group type: COMPARATOR
Intervention: Control group (no AT)
Number of subjects: 737
Study 18291345 — intervention group
Group type: EXPERIMENTAL
Intervention: Tecnis Z9001 IOL with modified anterior surface
Number of subjects: 25
Study 18291345 — intervention group
Group type: COMPARATOR
Intervention: ClariFlex IOL
Number of subjects: 25
Study 18291345 — intervention group
Group type: EXPERIMENTAL
Intervention: Tecnis Z9001 IOL
Number of subjects: 25
Study 16526896 — intervention group
Group type: EXPERIMENTAL
Intervention: Conjunctival reflectance spectra with PLS analysis
Number of subjects: 30
Study 16526896 — intervention group
Group type: EXPERIMENTAL
Intervention: Conjunctival reflectance spectra with discrete spectral region model
Number of subjects: 30
Study 16526896 — intervention group
Group type: COMPARATOR
Intervention: In vitro measurement of hemoglobin
Number of subjects: 30
Study 14594652 — intervention group
Group type: EXPERIMENTAL
Intervention: Controlled heading for 55 minutes
Number of subjects: 61
Study 14594652 — intervention group
Group type: COMPARATOR
Intervention: Normal exercise for 61 minutes
Number of subjects: 61
Study 14594652 — intervention group
Group type: COMPARATOR
Intervention: CCT+ group (patients after TBI)
Number of subjects: 61
Study 10630380 — intervention group
Group type: EXPERIMENTAL
Intervention: GLP-1 (0.4 pmol/min/kg body weight)
Number of subjects: 10
Study 10630380 — intervention group
Group type: EXPERIMENTAL
Intervention: GLP-1 (1.2 pmol/min/kg body weight)
Number of subjects: 10
Study 10630380 — intervention group
Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 10
Study 9360208 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrafiltrated whey formula
Number of subjects: 0
Study 9360208 — intervention group
Group type: COMPARATOR
Intervention: Electrodialyzed whey formula
Number of subjects: 0
Study 1548648 — intervention group
Group type: EXPERIMENTAL
Intervention: Controlled-release ketoprofen
Number of subjects: 50
Study 1548648 — intervention group
Group type: COMPARATOR
Intervention: Diclofenac
Number of subjects: 50
Study 2582017 — intervention group
Group type: EXPERIMENTAL
Intervention: Encainide (50 mg three times a day)
Number of subjects: 10
Study 2582017 — intervention group
Group type: EXPERIMENTAL
Intervention: Disopyramide (200 mg three times a day)
Number of subjects: 10
Study 2582017 — intervention group
Group type: EXPERIMENTAL
Intervention: Encainide
Number of subjects: 10
Study 2582017 — intervention group
Group type: EXPERIMENTAL
Intervention: Disopyramide
Number of subjects: 10
Study 31688331 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (0.5 μg/kg)
Number of subjects: 223
Study 31688331 — intervention group
Group type: COMPARATOR
Intervention: 0.9% sodium chloride (saline)
Number of subjects: 223
Study 31688331 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 223
Study 29882261 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-term ureter catheter for 6 hours
Number of subjects: 141
Study 29882261 — intervention group
Group type: COMPARATOR
Intervention: Double-J stent insertion for 5 days
Number of subjects: 141
Study 27411591 — intervention group
Group type: EXPERIMENTAL
Intervention: Dabigatran
Number of subjects: 5107
Study 27411591 — intervention group
Group type: COMPARATOR
Intervention: Warfarin
Number of subjects: 5107
Study 25057102 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic lumbar punctures (LPs)
Number of subjects: 248
Study 25057102 — intervention group
Group type: COMPARATOR
Intervention: No therapeutic lumbar punctures
Number of subjects: 248
Study 22661448 — intervention group
Group type: EXPERIMENTAL
Intervention: Neurally adjusted ventilatory assist (NAVA)
Number of subjects: 13
Study 22661448 — intervention group
Group type: COMPARATOR
Intervention: Pressure support ventilation (PSV)
Number of subjects: 13
Study 20692140 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide/formoterol 320/9 microg
Number of subjects: 111
Study 20692140 — intervention group
Group type: COMPARATOR
Intervention: Formoterol 9 microg
Number of subjects: 111
Study 20692140 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 111
Study 18797738 — intervention group
Group type: EXPERIMENTAL
Intervention: Inspiratory muscle training (IMT)
Number of subjects: 50
Study 18797738 — intervention group
Group type: COMPARATOR
Intervention: Control (monthly medical visits and education)
Number of subjects: 50
Study 15699225 — intervention group
Group type: EXPERIMENTAL
Intervention: Statin diet (20 mg lovastatin)
Number of subjects: 34
Study 15699225 — intervention group
Group type: EXPERIMENTAL
Intervention: Portfolio diet (high in plant sterols, soy-protein foods, almonds, viscous fibers)
Number of subjects: 34
Study 15699225 — intervention group
Group type: COMPARATOR
Intervention: Control diet (very-low-saturated-fat diet)
Number of subjects: 34
Study 12971709 — intervention group
Group type: EXPERIMENTAL
Intervention: General programme of psychomotor therapy
Number of subjects: 199